Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Form	Price
C09DA03	VIOSTAN PLUS 80/12.5	G	Valsartan - 80mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	547,520 L.L
D11AF	VERRUMAL	B	Fluorouracil - 0.5g/100g, Salicylic acid - 10g/100g	Solution	529,474 L.L
G04CA53	VESOMNI	B	Tamsulosin HCl - 0.4mg, Solifenacin succinate - 6mg	Tablet, modified release	4,491,122 L.L
C09DA03	VALUSTAR PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	592,635 L.L
A11DB	VITANOR	G	Vitamin B1 - 250mg, Vitamin B6 - 250mg, Vitamin B12 - 500mcg	Tablet, film coated	946,065 L.L
C09DA03	VIOSTAN PLUS 160/12.5	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	668,082 L.L
C09DA03	VIOSTAN PLUS 160/25	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg	Tablet, film coated	671,921 L.L
C09DA03	VIOSTAN PLUS 320/25	G	Valsartan - 320mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,445,975 L.L
C09DA03	VIOSTAN PLUS 320/12.5	G	Valsartan - 320mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,411,419 L.L
A12AX	VITAQPLUS	G	Vitamin K2 - 0.05mg, Colecalciferol - 400IU, Calcium - 300mg	Tablet	2,500,891 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg	Tablet, film coated	933,971 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	933,971 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg	Tablet, film coated	900,374 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	900,374 L.L
C09DB01	VIOSTAN AM 160/5	G	Amlodipine besylate - 5mg, Valsartan - 160mg	Tablet, film coated	1,177,206 L.L
C09DB01	VIOSTAN AM 160/10	G	Amlodipine besylate - 10mg, Valsartan - 160mg	Tablet, film coated	1,177,206 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 20mg, Amlodipine besylate - 5mg	Tablet, film coated	971,598 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 40mg, Amlodipine besylate - 5mg	Tablet, film coated	1,103,295 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 40mg, Amlodipine besylate - 10mg	Tablet, film coated	1,186,613 L.L
D02AF	VERRUFILM	G	Lactic acid - 16.7%, Salicylic acid - 16.7%	Solution	861,403 L.L
C09DX01	VIOSTAN AM PLUS 160/5/25	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,196,020 L.L
C09DX01	VIOSTAN AM PLUS 160/10/12.5	G	Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,196,020 L.L
C09DX01	VIOSTAN AM PLUS 160/10/25	G	Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,196,020 L.L
C09DX01	VIOSTAN AM PLUS 160/5/12.5	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,196,020 L.L
C09DX01	VIOSTAN AM PLUS 320/10/25	G	Valsartan - 320mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,881,380 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 20mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,482,258 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,523,917 L.L

...